131 related articles for article (PubMed ID: 38426664)
1. Acquired perforating dermatoses and cabozantinib: A novel cutaneous toxicity.
Soto-García D; Suh-Oh HJ; Álvarez C; Martínez-Fernández S; García-Arroyo FR; Couselo-Rodríguez C; Flórez Á
J Dtsch Dermatol Ges; 2024 Apr; 22(4):594-596. PubMed ID: 38426664
[No Abstract] [Full Text] [Related]
2. [Not Available].
Soto-García D; Suh-Oh HJ; Álvarez C; Martínez-Fernández S; García-Arroyo FR; Couselo-Rodríguez C; Flórez Á
J Dtsch Dermatol Ges; 2024 Apr; 22(4):594-596. PubMed ID: 38574028
[No Abstract] [Full Text] [Related]
3. Uncharted surgical therapy for acquired perforating dermatoses.
Izzat MB; Kahila A; Izzat AW; Zamlout A; Alashi S
Asian Cardiovasc Thorac Ann; 2023 Feb; 31(2):148-150. PubMed ID: 36314683
[TBL] [Abstract][Full Text] [Related]
4. Acquired perforating dermatoses in patients with diabetic kidney disease on hemodialysis.
Hari Kumar KV; Prajapati J; Pavan G; Parthasarathy A; Jha R; Modi KD
Hemodial Int; 2010 Jan; 14(1):73-7. PubMed ID: 19758294
[TBL] [Abstract][Full Text] [Related]
5. Acquired perforating dermatosis in a patient with chronic renal failure and diabetes mellitus.
Keough GC; Hivnor CM; Elston DM; McCollough ML
Cutis; 1998 Aug; 62(2):94-6. PubMed ID: 9714906
[TBL] [Abstract][Full Text] [Related]
6. [Acquired reactive perforating collagenosis in diabetes mellitus].
Wigger-Alberti W; Richter M; Hochheim B; Schreiber G; Elsner P
Dtsch Med Wochenschr; 1999 Mar; 124(10):282-4. PubMed ID: 10191822
[TBL] [Abstract][Full Text] [Related]
7. Acquired perforating dermatosis in a patient with chronic renal failure.
Fernandes KA; Lima LA; Guedes JC; Lima RB; D'Acri AM; Martins CJ
An Bras Dermatol; 2016; 91(5 suppl 1):10-13. PubMed ID: 28300880
[TBL] [Abstract][Full Text] [Related]
8. Dermatological Manifestations in Patients With Chronic Kidney Disease: A Review.
Arriaga Escamilla D; Lakhani A; Antony S; Salazar Villegas KN; Gupta M; Ramnath P; Murillo Pineda MI; Bedor A; Banegas D; Calderon Martinez E
Cureus; 2024 Jan; 16(1):e52253. PubMed ID: 38352109
[TBL] [Abstract][Full Text] [Related]
9. Acquired perforating dermatoses show increased levels of cutaneous advanced glycation end-products.
Bellinato F; Maurelli M; Gisondi P; Girolomoni G
Clin Exp Dermatol; 2022 Jan; 47(1):80-85. PubMed ID: 34260091
[TBL] [Abstract][Full Text] [Related]
10. Pruritic Periumbilical Plaque as a Presentation of a Rare Perforating Dermatosis.
Bathina M; Hegde SP; Shanavaz AA; Saldanha PP
Indian Dermatol Online J; 2020; 11(1):68-71. PubMed ID: 32055513
[TBL] [Abstract][Full Text] [Related]
11. Acquired perforating dermatosis: clinicopathological features in twenty-two cases.
Saray Y; Seçkin D; Bilezikçi B
J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):679-88. PubMed ID: 16836495
[TBL] [Abstract][Full Text] [Related]
12. Perforating dermatoses: a review and report of four cases.
Sehgal VN; Jain S; Thappa DM; Bhattacharya SN; Logani K
J Dermatol; 1993 Jun; 20(6):329-40. PubMed ID: 8349922
[TBL] [Abstract][Full Text] [Related]
13. Dermatomyositis, clinically presenting with cutaneous ulcers, with histopathologic evidence of perforating collagenosis.
Rosenstein R; Martires K; Christman M; Terushkin V; Meehan SA; Seminara N; Golden BD; Franks AG
Dermatol Online J; 2016 Dec; 22(12):. PubMed ID: 28329555
[TBL] [Abstract][Full Text] [Related]
14. [Acquired reactive perforating dermatosis. Successful treatment with allopurinol in 2 cases].
Krüger K; Tebbe B; Krengel S; Goerdt S; Orfanos CE
Hautarzt; 1999 Feb; 50(2):115-20. PubMed ID: 10097954
[TBL] [Abstract][Full Text] [Related]
15. Kyrle disease and acquired perforating collagenosis secondary to chronic renal failure and diabetes mellitus.
Schreml S; Hafner C; Eder F; Landthaler M; Burgdorf W; Babilas P
Case Rep Dermatol; 2011 Sep; 3(3):209-11. PubMed ID: 22087093
[TBL] [Abstract][Full Text] [Related]
16. Clinical practice guide for the treatment of perforating dermatosis.
Kawakami T; Akiyama M; Ishida-Yamamoto A; Nakano H; Mitoma C; Yoneda K; Suga Y
J Dermatol; 2020 Dec; 47(12):1374-1382. PubMed ID: 33094871
[TBL] [Abstract][Full Text] [Related]
17. Perforating disorder secondary to leflunomide and review of the literature of medications associated with perforating disorder.
Keeley JM; Pavlidakey P; Sami N
Dermatol Online J; 2018 May; 24(5):. PubMed ID: 30142734
[TBL] [Abstract][Full Text] [Related]
18. Acquired reactive perforating collagenosis combined with MRSA: A case report.
Huang F; Ren W; Wang M; Li X; Pan M
Med Int (Lond); 2023; 3(1):9. PubMed ID: 36793622
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
